2-amino-5-phosphonovalerate and Decerebrate Posturing
2-amino-5-phosphonovalerate has been researched along with Decerebrate Posturing in 16 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
Research
Studies (16)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Peever, JH | 1 |
| Lai, YY | 1 |
| Siegel, JM | 1 |
| Giroux, N | 1 |
| Chau, C | 1 |
| Barbeau, H | 1 |
| Reader, TA | 1 |
| Rossignol, S | 1 |
| Zuperku, EJ | 1 |
| Brandes, IF | 1 |
| Stucke, AG | 1 |
| Sanchez, A | 1 |
| Hopp, FA | 1 |
| Stuth, EA | 1 |
| Radhakrishnan, V | 1 |
| Henry, JL | 1 |
| Karius, DR | 1 |
| Ling, L | 1 |
| Speck, DF | 1 |
| Douglas, JR | 1 |
| Noga, BR | 1 |
| Dai, X | 1 |
| Jordan, LM | 1 |
| Kessler, JP | 2 |
| Nattie, EE | 1 |
| Gdovin, M | 1 |
| Li, A | 1 |
| Adreani, CM | 1 |
| Hill, JM | 2 |
| Kaufman, MP | 1 |
| Bhatnagar, T | 1 |
| Chitravanshi, VC | 1 |
| Sapru, HN | 1 |
| Ptak, K | 1 |
| Konrad, M | 1 |
| Di Pasquale, E | 1 |
| Tell, F | 1 |
| Hilaire, G | 1 |
| Monteau, R | 1 |
| Gee, BY | 1 |
| Tjen-A-Looi, SC | 1 |
| Chahal, PS | 1 |
| Longhurst, JC | 1 |
| Pierrefiche, O | 1 |
| Schmid, K | 1 |
| Foutz, AS | 1 |
| Denavit-Saubie, M | 1 |
| Jean, A | 1 |
| Raigorodsky, G | 1 |
| Urca, G | 1 |
| Lin, TB | 1 |
Other Studies
16 other studies available for 2-amino-5-phosphonovalerate and Decerebrate Posturing
| Article | Year |
|---|---|
Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism.
Topics: 2-Amino-5-phosphonovalerate; Animals; Carrier Proteins; Cats; Decerebrate State; Dose-Response Relat | 2003 |
Effects of intrathecal glutamatergic drugs on locomotion. II. NMDA and AP-5 in intact and late spinal cats.
Topics: 2-Amino-5-phosphonovalerate; Adrenergic alpha-Antagonists; Animals; Cats; Decerebrate State; Electri | 2003 |
Major components of endogenous neurotransmission underlying the discharge activity of hypoglossal motoneurons in vivo.
Topics: 2-Amino-5-phosphonovalerate; Animals; Bicuculline; Decerebrate State; Dogs; Excitatory Amino Acid An | 2008 |
Excitatory amino acid receptor mediation of sensory inputs to functionally identified dorsal horn neurons in cat spinal cord.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4- | 1993 |
Nucleus tractus solitarius and excitatory amino acids in afferent-evoked inspiratory termination.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Blood Press | 1994 |
The effects of intrathecal administration of excitatory amino acid agonists and antagonists on the initiation of locomotion in the adult cat.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Cats; Decer | 1993 |
Involvement of excitatory amino acids in the activity of swallowing-related neurons of the ventro-lateral medulla.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Decerebrate State; Deglu | 1993 |
Retrotrapezoid nucleus glutamate receptors: control of CO2-sensitive phrenic and sympathetic output.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Blood Pressure; Carbon D | 1993 |
Intrathecal blockade of both NMDA and non-NMDA receptors attenuates the exercise pressor reflex in cats.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Blood Pressure; Cats; De | 1996 |
Cardiovascular responses to microinjections of excitatory amino acids into the area postrema of the rat.
Topics: 2-Amino-5-phosphonovalerate; Anesthetics, Intravenous; Animals; Blood Pressure; Bradycardia; Cerebra | 1999 |
Cellular and synaptic effect of substance P on neonatal phrenic motoneurons.
Topics: 2-Amino-5-phosphonovalerate; 4-Aminopyridine; Action Potentials; Animals; Animals, Newborn; Brain St | 2000 |
Role of spinal NMDA and non-NMDA receptors in the pressor reflex response to abdominal ischemia.
Topics: 2-Amino-5-phosphonovalerate; Abdomen; Animals; Baroreflex; Cats; Decerebrate State; Excitatory Amino | 2002 |
Endogenous activation of NMDA and non-NMDA glutamate receptors on respiratory neurones in cat medulla.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Cats; Decerebrate State; Iontophoresis; Medulla O | 1991 |
Evidence that activation of N-methyl-D-aspartate (NMDA) and non-NMDA receptors within the nucleus tractus solitarii triggers swallowing.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Decerebrate State; Deglu | 1991 |
Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems.
Topics: 2-Amino-5-phosphonovalerate; Analgesia; Animals; Aspartic Acid; Behavior, Animal; Decerebrate State; | 1987 |
Tetanization-induced pelvic-to-pudendal reflex plasticity in anesthetized rats.
Topics: Animals; Bicuculline; Decerebrate State; Electric Stimulation; Excitatory Amino Acid Agonists; Excit | 2004 |